RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

AstraZeneca Plc

A collection of news and information related to AstraZeneca Plc published by this site and its partners.

Top AstraZeneca Plc Articles see all

Displaying items 1-5
  • Acciones europeas caen presionadas por sector farmacéutico

    LONDRES (Reuters) - Una caída en las principales acciones de compañías farmacéuticas, luego de que AstraZeneca trató de minimizar especulaciones acerca de una nueva oferta de compra de parte de Pfizer, hizo retroceder el martes a los mercados bursátiles europeos.
  • Exclusive: 'Back to normal' for AstraZeneca CEO, despite Pfizer rumors

    BARCELONA (Reuters) - Though speculation is rife of a new Pfizer bid, AstraZeneca's chief executive is not holed up with advisers in London or New York. Instead, he has spent the last three days immersed in heart science in Barcelona. "The only thing I...

    Roche to buy U.S. biotech firm InterMune for $8.3 billion

    Roche to buy U.S. biotech firm InterMune for $8.3 billion
    Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc. for $8.3 billion in cash, helping the world's leading maker of cancer drugs expand into the treatment of rare or incurable diseases. Roche's efforts to produce successful non-...

    U.S. investors switch out of Europe as recovery bet sours

    LONDON (Reuters) - U.S. investors are withdrawing billions of dollars from European stocks as signs of a stalled economic recovery, compounded by the Ukraine crisis, halt the past year's scramble to buy back into the region. The switch out of Europe into...

    AstraZeneca and Mitsubishi Tanabe link on diabetes research

    LONDON (Reuters) - AstraZeneca and Mitsubishi Tanabe Pharma said on Wednesday they said signed a three-year research collaboration into diabetic nephropathy, or kidney failure due to diabetes. The deal will focus on early-stage research and the hope is...